Showing results (91-100 of 120) with videos related to
Sort By:
Pageof 12
Clinical Genetics|April 30, 2013
Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in MontrealP Ghadirian, A Robidoux, E Nassif, et al.Clinical Genetics|September 13, 2006
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descentK K Oros, P Ghadirian, C M Maugard, et al.Lancet (London, England)|May 30, 2001
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyS A Narod, P Sun, P Ghadirian, et al.Seminars in Oncology|April 1, 1996
Familial pancreatic cancer: a reviewH T Lynch, T Smyrk, S E Kern, et al.Current Oncology (Toronto, Ont.)|April 26, 2014
A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriersS A Narod, N Tung, J Lubinski, et al.American Journal of Human Genetics|October 30, 1998
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer familiesP N Tonin, A M Mes-Masson, P A Futreal, et al.International Journal of Cancer|May 28, 1992
A collaborative case-control study of nutrient intake and pancreatic cancer within the search programmeG R Howe, P Ghadirian, H B Bueno de Mesquita, et al.Lancet (London, England)|December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupS A Narod, J S Brunet, P Ghadirian, et al.Lancet (London, England)|December 10, 1999
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2H Jernström, C Lerman, P Ghadirian, et al.British Journal of Cancer|April 14, 2011
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriersK Metcalfe, S Gershman, H T Lynch, et al.Pageof 12